28 Jan 2020
09:35-10:55
Hall 8
Back
Modelling breast cancer – moving closer to the clinic
HORMONES AND BREAST CANCER – WHY MODELS MATTER
Cathrin Brisken
A NEW 3D MODEL FOR BREAST CANCER – ALTERNATIVES TO XENOGRAFTS AND PDX
Gillian Farnie
THE CHALLENGES OF MEASURING THE RESPONSE TO IMMUNOTHERAPIES IN VIVO
Jonas Nillson
CHAIRS: Ingunn Holen & Rob Clarke